Search results
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 14 hours agoSen. Bernie Sanders blasted the Danish drugmaker Novo Nordisk this week for charging U.S. residents...
Bankruptcy allowed Mallinckrodt to end Acthar royalties, 3rd Circ. rules
Reuters· 6 hours agoMallinckrodt's bankruptcy permitted the drug company to end a perpetual royalty agreement with...
Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
Pharmaceutical Technology via Yahoo Finance· 7 hours agoSanders had previously put forth a proposal to cap prices on federally-funded drugs in 2023...of...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 2 days agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
Weight loss drugs such as Ozempic, Wegovy could spell trouble for the diet industry
New York Post· 5 hours agoAt least 3 million prescriptions for the class of medications known as GLP-1 agonists were issued...
How bird flu virus fragments get into milk sold in stores, and what the spread of H5N1 in cows means...
The Conversation via Yahoo News· 44 minutes agoFive livestock experts who study infectious diseases in the dairy industry explain the risks as the...
Justice Department is investigating McKinsey consulting firm’s role in opioid epidemic
CNN via Yahoo News· 7 hours agoThe Justice Department is investigating McKinsey & Company, one of the world’s largest consulting...
Q1 2024 Bristol-Myers Squibb Co Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 39 minutes agoAs you'll note, we've posted slides to bms.com that you can use to follow along with for Chris... we get started, I'll read our forward-looking statement. During this call, we'll make statements ...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 17 hours ago-thirds of the savings is expected to come out of Bristol Myers’ spending on research and...
Gilead's quarterly loss is narrower than expected
Morningstar· 7 hours agoGilead Sciences Inc.'s stock rose 0.8% in after-hours trading Thursday, after the drug company's adjusted first-quarter profit was narrower than expected ...
